Why Asia-Pacific Attracts 60% of All Hepatology Trials Globally (IMAGE)

Digital Mantra Group

Why Asia-Pacific Attracts 60% of All Hepatology Trials Globally

Caption

The leading Asia-Pacific biotech specialist CRO Novotech is again collaborating with the prestigious biotech and pharma news platform Endpoints News. This webinar focusses on the reasons why the Asia-Pacific is attracting 60% of ongoing and planned hepatology trials globally (source GlobalData).

Credit

Novotech

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.